<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang M</submitter><funding>Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System</funding><funding>Sichuan Province Science and Technology Support Program</funding><funding>National Natural Science Foundation of China</funding><funding>Ministry of Oceans and Fisheries</funding><pagination>102450</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9841290</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>102(3)</volume><pubmed_abstract>Riemerella anatipestifer (R. anatipestifer, RA) is an infectious pathogen that causes septicemia and polyserositis in ducks. Our previous studies showed that RA CH-1 ∆fur was significantly attenuated in ducklings, which highlights the potential of this strain as a live attenuated vaccine. In this study, it was shown that infection with 10&lt;sup>9&lt;/sup> CFU of the fur mutant did not cause any clinical symptoms or significant histological lesions in 3-day-old ducklings and that the bacteria were readily cleared by the host within 3 d. Compared with the nonvaccinated group, the group inoculated with the mutant strain RA CH-1 ∆fur exhibited protection of ducklings against a high-dose (2.28 × 10&lt;sup>10&lt;/sup> CFU) challenge with the wild-type strain RA CH-1. Moreover, the average body weights and </pubmed_abstract><journal>Poultry science</journal><pubmed_title>Evaluation of the immunoprotection efficacy of Riemerella anatipestifer fur-deficient mutant as an attenuated vaccine.</pubmed_title><pmcid>PMC9841290</pmcid><funding_grant_id>SCCXTD-2020-18</funding_grant_id><funding_grant_id>32072825</funding_grant_id><funding_grant_id>2020YJ0344</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Mao S</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Cheng A</pubmed_authors><pubmed_authors>Huang M</pubmed_authors><pubmed_authors>Tian B</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Zhu D</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Gao Q</pubmed_authors><pubmed_authors>Jia R</pubmed_authors><pubmed_authors>Sun D</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Ou X</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of the immunoprotection efficacy of Riemerella anatipestifer fur-deficient mutant as an attenuated vaccine.</name><description>Riemerella anatipestifer (R. anatipestifer, RA) is an infectious pathogen that causes septicemia and polyserositis in ducks. Our previous studies showed that RA CH-1 ∆fur was significantly attenuated in ducklings, which highlights the potential of this strain as a live attenuated vaccine. In this study, it was shown that infection with 10&lt;sup>9&lt;/sup> CFU of the fur mutant did not cause any clinical symptoms or significant histological lesions in 3-day-old ducklings and that the bacteria were readily cleared by the host within 3 d. Compared with the nonvaccinated group, the group inoculated with the mutant strain RA CH-1 ∆fur exhibited protection of ducklings against a high-dose (2.28 × 10&lt;sup>10&lt;/sup> CFU) challenge with the wild-type strain RA CH-1. Moreover, the average body weights and </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-26T10:00:25.052Z</modification><creation>2025-04-06T13:11:08.286Z</creation></dates><accession>S-EPMC9841290</accession><cross_references><pubmed>36621099</pubmed><doi>10.1016/j.psj.2022.102450</doi></cross_references></HashMap>